Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

PRP helps hair regrowth and thickness.

Microneedling combined with platelet-rich plasma therapy is more effective for hair regrowth in androgenic alopecia than microneedling alone, but it's more painful.

Optimal transplant density for Chinese male hair loss patients is 35-50 hair/cm², with minimum 106.88 hair/cm² left in donor area for esthetic satisfaction.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

Different hair loss patterns may be linked to varying male hormone levels.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Finasteride effectively treats hair loss in men with minimal side effects.

AGA can occur in children with family history; early diagnosis and treatment important.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

Minoxidil-loaded NLC gel shows potential for effective alopecia treatment.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Ruxolitinib can help regrow hair in severe alopecia areata.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Citrullus colocynthis fruit extract may effectively treat testosterone-related hair loss, similar to finasteride.